Literature DB >> 22537435

HCV infection and metabolic syndrome: which is the chicken and which is the egg?

Francesco Negro1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22537435     DOI: 10.1053/j.gastro.2011.12.063

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  14 in total

1.  Treatment of HCV in renal transplant patients with peginterferon and ribavirin: long-term follow-up.

Authors:  Siu-Ka Mak; Ho-Kwan Sin; Kin-Yee Lo; Man-Wai Lo; Shuk-Fan Chan; Kwok-Chi Lo; Yuk-Yi Wong; Lo-Yi Ho; Ping-Nam Wong; Andrew K M Wong
Journal:  Clin Exp Nephrol       Date:  2017-01-12       Impact factor: 2.801

Review 2.  Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.

Authors:  Umberto Vespasiani-Gentilucci; Paolo Gallo; Antonio De Vincentis; Giovanni Galati; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

3.  The strange and critical intersection of hepatitis C and lipoprotein metabolism: "C-zing" the oil.

Authors:  Stephen Caldwell; Kyle L Hoehn; Young S Hahn
Journal:  Hepatology       Date:  2012-12-12       Impact factor: 17.425

4.  Adiponectin and visfatin may serve as diagnosis markers for metabolic syndrome in Uygur population.

Authors:  Xi Chang; Yi Jiao; Jianfei Lu; Yanjiao Wang; Kelim Abudureyimu; Cheng Zhang; Nuerbiye Nuermaimaiti; Xian Gong; Yiliyasi Aisa; Yaqun Guan
Journal:  Int J Clin Exp Med       Date:  2014-11-15

5.  Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1-infected patients.

Authors:  Eric G Meissner; Yu-Jin Lee; Anu Osinusi; Zayani Sims; Jing Qin; Dan Sturdevant; John McHutchison; Mani Subramanian; Maureen Sampson; Susanna Naggie; Keyur Patel; Alan T Remaley; Henry Masur; Shyam Kottilil
Journal:  Hepatology       Date:  2015-01-28       Impact factor: 17.425

Review 6.  Significance of hepatitis virus infection in the oncogenic initiation of hepatocellular carcinoma.

Authors:  Caecilia H C Sukowati; Korri E El-Khobar; Susan I Ie; Beatrice Anfuso; David H Muljono; Claudio Tiribelli
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

7.  Therapy with Oral Directly Acting Agents in Hepatitis C Infection Is Associated with Reduction in Fibrosis and Increase in Hepatic Steatosis on Transient Elastography.

Authors:  Gyanranjan Rout; Baibaswata Nayak; Arpan H Patel; Deepak Gunjan; Vishwajeet Singh; Saurabh Kedia
Journal:  J Clin Exp Hepatol       Date:  2018-06-21

8.  Retrospective study of the associations between hepatitis C virus infection and metabolic factors.

Authors:  Shira Yair-Sabag; Elchanan Nussinson; Ofir Ben-Assuli; Fahmi Shibli; Azmi Shahbari; Shira Zelber-Sagi
Journal:  World J Hepatol       Date:  2016-10-28

Review 9.  Hepatitis C virus and cardiovascular: A review.

Authors:  Salvatore Petta
Journal:  J Adv Res       Date:  2016-06-18       Impact factor: 10.479

Review 10.  Hepatic steatosis in HCV-infected persons in the direct-acting antiviral era.

Authors:  Heather L Stevenson; Netanya S Utay
Journal:  Trop Dis Travel Med Vaccines       Date:  2016-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.